Covance Inc. (NYSE: CVD) reported lower second quarter earnings that dropped to 49 cents per share from 67 cents per share a year earlier and forecast third quarter income well below expectations. Shares of the drug development services company plummeted $9.97 to close at $39.65.
Covance Disappoints
July 29, 2010 at 17:23 PM EDT
